|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0016011,
umls-concept:C0019134,
umls-concept:C0021467,
umls-concept:C0021469,
umls-concept:C0150099,
umls-concept:C0168273,
umls-concept:C0205547,
umls-concept:C0522523,
umls-concept:C1274040,
umls-concept:C1522318,
umls-concept:C1549071,
umls-concept:C1948041
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2004-11-2
|
|
pubmed:abstractText |
The purpose of this study was to compare the cost of percutaneous coronary intervention (PCI) using bivalirudin with provisional platelet glycoprotein (GP) IIb/IIIa inhibition with that of heparin + routine GP IIb/IIIa inhibition.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
2
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1792-800
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15519009-Aged,
pubmed-meshheading:15519009-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15519009-Anticoagulants,
pubmed-meshheading:15519009-Combined Modality Therapy,
pubmed-meshheading:15519009-Coronary Disease,
pubmed-meshheading:15519009-Costs and Cost Analysis,
pubmed-meshheading:15519009-Double-Blind Method,
pubmed-meshheading:15519009-Drug Therapy, Combination,
pubmed-meshheading:15519009-Female,
pubmed-meshheading:15519009-Follow-Up Studies,
pubmed-meshheading:15519009-Heparin,
pubmed-meshheading:15519009-Hirudins,
pubmed-meshheading:15519009-Hospitalization,
pubmed-meshheading:15519009-Humans,
pubmed-meshheading:15519009-Male,
pubmed-meshheading:15519009-Middle Aged,
pubmed-meshheading:15519009-Peptide Fragments,
pubmed-meshheading:15519009-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:15519009-Recombinant Proteins,
pubmed-meshheading:15519009-Treatment Outcome,
pubmed-meshheading:15519009-United States
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial.
|
|
pubmed:affiliation |
Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. dcohen@caregroup.harvard.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
